卵磷脂络合碘治疗玻璃体切割术后玻璃体混浊临床分析  

Clinical study of Jolethin in treating vitreous opacity after vitrectomy

作　　者：黄永盛[1] 梁小玲[1] 杨秀霞[1] 于珊珊[1] 陈方[1] 唐仕波[1] 

机构地区：[1]中山大学中山眼科中心,眼科学国家重点实验室,广州510060

出　　处：《中国实用眼科杂志》2009年第10期1144-1145,共2页Chinese Journal of Practical Ophthalmology

摘　　要：目的 观察卵磷脂络合碘对玻璃体切割术后玻璃体炎症反应混浊的治疗效果.方法 视网膜静脉阻塞引起的玻璃体积血患者44例（44只眼）,行标准三切口玻璃体切割、眼内光凝术.术后随机分为两组,A组口服卵磷脂络合碘,B组仅应用糖皮质激素.分别于术后2、4、8周对患者进行随访并记录患眼玻璃体混浊的等级.结果 玻璃体切割术后2、4、8周,A组与B组之间玻璃体混浊的等级差异均有统计学意义（P＜0.05）,A组低于B组.结论 卵磷脂络合碘可有效地促进玻璃体切割术后玻璃体混浊的吸收.Objective To Investigate the efficacy of Jolethin in treating vitreous inflammative opacity after vitrectomy. Methods Forty-four consecutive cases （44 eyes） with vitreous hemorrhage received standard three-port vitrectomy and laser photocoagulation.After surgery, all the patients were randomly divided into two groups.Jolethin were applied in group A, and only corticosteroid was administrated in group B.Postoperative follow-up was scheduled in 2, 4 and 8 weeks, and the grade of vitreous opacity was recorded. Results In 2, 4 and 8 weeks after vitrectomy, vitreous opacity was significantly improved in the eyes in group A.The num- bers of eyes with grade 1 of vitreous opacity was more than group B statistically, and those with grade 2 and 3 of vitreous opacity were less than group B in various postoperative week （P〈0.05）. Conclusions Jolethin can effectively accelerate the absorption of vitreous opacity after vitrectomy.

关 键 词：玻璃体切割术 玻璃体混浊 卵磷脂络合碘 

分 类 号：R779.6[医药卫生—眼科] R977[医药卫生—临床医学]